当前位置:首页 - 行情中心 - 津药药业(600488) - 财务分析 - 现金流量表

津药药业

(600488)

  

流通市值:56.45亿  总市值:56.45亿
流通股本:10.92亿   总股本:10.92亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,640,178,656.781,164,709,282.21574,418,388.842,402,733,620.55
  收到的税费返还101,017,821.3755,067,745.863,532,630.16103,877,162.46
  收到其他与经营活动有关的现金32,080,232.4115,559,851.916,751,690.1967,838,698.33
  经营活动现金流入小计1,773,276,710.561,235,336,879.98584,702,709.192,574,449,481.34
  购买商品、接受劳务支付的现金770,173,485.83548,800,601.68309,062,320.931,348,889,986.88
  支付给职工以及为职工支付的现金432,053,477.83306,185,524.2190,270,934.78587,244,926.79
  支付的各项税费161,413,068.83112,407,338.5861,668,237.27233,805,562.21
  支付其他与经营活动有关的现金109,947,425.0376,165,112.6635,053,517.82268,029,342.5
  经营活动现金流出小计1,473,587,457.521,043,558,577.12596,055,010.82,437,969,818.38
  经营活动产生的现金流量净额299,689,253.04191,778,302.86-11,352,301.61136,479,662.96
二、投资活动产生的现金流量:
  收回投资收到的现金---8,182,019
  取得投资收益收到的现金00-1,685,119.85
  处置固定资产、无形资产和其他长期资产收回的现金净额995,826.76315,30513,5007,790,000
  收到的其他与投资活动有关的现金---109,692,000
  投资活动现金流入小计995,826.76315,30513,500127,349,138.85
  购建固定资产、无形资产和其他长期资产支付的现金28,069,067.5117,712,135.316,685,345.255,910,613.05
  投资支付的现金129,502,800--20,400,000
  支付其他与投资活动有关的现金---0
  投资活动现金流出小计157,571,867.5117,712,135.316,685,345.276,310,613.05
  投资活动产生的现金流量净额-156,576,040.75-17,396,830.31-6,671,845.251,038,525.8
三、筹资活动产生的现金流量:
  取得借款收到的现金100,000,000100,000,00026,000,000329,129,071.2
  筹资活动现金流入小计100,000,000100,000,00026,000,000329,129,071.2
  偿还债务支付的现金220,797,119.02188,474,391.02105,754,391.02127,114,561.6
  分配股利、利润或偿付利息支付的现金116,716,367.8644,998,139.644,527,621.04142,772,809.12
  其中:子公司支付给少数股东的股利、利润---15,725,447.98
  支付其他与筹资活动有关的现金34,873,868.9233,655,769.0217,828,241.0645,163,522.1
  筹资活动现金流出小计372,387,355.8267,128,299.68128,110,253.12315,050,892.82
  筹资活动产生的现金流量净额-272,387,355.8-167,128,299.68-102,110,253.1214,078,178.38
四、汇率变动对现金及现金等价物的影响-6,132,946.76-3,990,465.81-1,952,594.2710,064.63
五、现金及现金等价物净增加额-135,407,090.273,262,707.06-122,086,994.2201,606,431.77
  加:期初现金及现金等价物余额808,789,626.36796,173,029.4796,173,029.4594,566,597.63
  期末现金及现金等价物余额673,382,536.09799,435,736.46674,086,035.2796,173,029.4
补充资料:
  净利润-51,406,494.21-122,054,932.22
  资产减值准备-5,443,269.46-61,200,398.79
  固定资产和投资性房地产折旧-116,391,177.54-247,327,521.74
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-116,391,177.54-247,327,521.74
  无形资产摊销-25,976,602.7-48,249,536.41
  长期待摊费用摊销---0
  处置固定资产、无形资产和其他长期资产的损失-417,617.12--404,023.42
  固定资产报废损失---4,961,158.7
  公允价值变动损失---0
  财务费用-17,609,330.21-23,991,334.62
  投资损失-86,469.86-798,682.63
  递延所得税-11,747,685.38--21,953,027.34
  其中:递延所得税资产减少-8,119,095.97--21,661,474.31
    递延所得税负债增加-3,628,589.41--291,553.03
  存货的减少--38,171,801.03-65,261,950.18
  经营性应收项目的减少--34,139,214.16--276,785,803.7
  经营性应付项目的增加-30,981,182.75--138,478,763.29
  其他---0
  债务转为资本---0
  一年内到期的可转换公司债券---0
  融资租入固定资产---0
  现金的期末余额-799,435,736.46-796,173,029.4
  减:现金的期初余额-796,173,029.4-594,566,597.63
  加:现金等价物的期末余额---0
  减:现金等价物的期初余额---0
  现金及现金等价物的净增加额-3,262,707.06-201,606,431.77
公告日期2026-10-242026-08-262026-04-252026-04-25
审计意见(境内)标准无保留意见
TOP↑